Anavex is a pharmaceutical company engaged in the development of drug candidates.
Quote | Anavex Life Sciences Corp. (NASDAQ:AVXL)
|Last Trade Date Time:||12/11/2023 03:00:00 am|
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
2023-12-05 03:58:10 ET Summary Investing in most current Alzheimer's drug companies is not recommended because they are not likely to modify the disease. Compounds that inhibit oxidative stress may only slow down the progression of Alzheimer's disease over the short term. Anav...
2023-11-29 07:21:25 ET Summary The EU recommends Anavex proceed with a full approval application for Alzheimer's drug Blarcamesine based on full Phase 2b/3 trial data. The U.S. FDA may grant accelerated approval to Anavex's Blarcamesine based on biomarker data alone. Blarcamesine ...
Message Board Posts | Anavex Life Sciences Corp. (NASDAQ:AVXL)
|For starters, here's an interview with Wes Christian...||bas2020||investorshub||12/11/2023 3:26:09 AM|
|Can you recommend any of these books that||BesaoT35||investorshub||12/11/2023 1:58:21 AM|
|It sure would be nice to get some news.||mike_dotcom||investorshub||12/11/2023 1:54:41 AM|
|Should you BUY IN THE PREMARKET BEFORE THE||georgejjl||investorshub||12/11/2023 1:43:46 AM|
|So far, Anavex has been very successful.||Hoskuld||investorshub||12/11/2023 1:01:05 AM|
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
Anavex Life Sciences Corp. Website:
U.S. stocks traded mixed toward the end of trading on Monday. The Dow traded down 0.13% to 35,344.56 while the NASDAQ rose 0.11% to 14,266.69....
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial r...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite moving higher on Monday. The Dow traded down 0.23% to 35,310.40 while th...